The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 03, 2025

Filed:

Apr. 05, 2024
Applicant:

Nutrition & Biosciences Usa 4, Inc., Rochester, NY (US);

Inventors:

Kyle Hyun Chang Kim, Wilmington, DE (US);

Yefim Brun, Wilmington, DE (US);

Lucia Daniela Ionescu, Oegstgeest, NL;

Juan David Londono, Bear, DE (US);

Jorge Mok, Wilmington, DE (US);

James Joshua Ohane, West Chester, PA (US);

Lemuel Tong, Kingston, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C08B 37/00 (2006.01); A23B 2/746 (2025.01); A23B 7/154 (2006.01); A23B 7/16 (2006.01); A61K 8/73 (2006.01); A61K 47/36 (2006.01); A61Q 17/04 (2006.01); C08L 7/00 (2006.01); C08L 75/04 (2006.01); C09D 7/65 (2018.01); C09D 175/04 (2006.01); D21H 17/24 (2006.01); D21H 19/12 (2006.01);
U.S. Cl.
CPC ...
C08B 37/0009 (2013.01); A23B 2/746 (2025.01); A23B 7/154 (2013.01); A23B 7/16 (2013.01); A61K 8/73 (2013.01); A61K 47/36 (2013.01); A61Q 17/04 (2013.01); C08L 7/00 (2013.01); C08L 75/04 (2013.01); C09D 7/65 (2018.01); C09D 175/04 (2013.01); D21H 17/24 (2013.01); D21H 19/12 (2013.01); A23V 2002/00 (2013.01); A61K 2800/10 (2013.01);
Abstract

Disclosed herein are compositions comprising insoluble alpha-glucan particles having a high degree of crystallinity and small particle size. For example, the alpha-glucan particles can have a degree of crystallinity of at least about 0.65, and/or an average size of less than a micron. At least 50% of the glycosidic linkages of the insoluble alpha-glucan in the disclosed particles are alpha-1,3 glycosidic linkages. Further disclosed are methods of producing insoluble alpha-glucan particles, as well as their use in various applications and products.


Find Patent Forward Citations

Loading…